STAT signalling in the heart and cardioprotection
Surinder M Soond1, David S Latchman, Anastasis Stephanou
1Institute of Child Health, University College London, London, WC1N 1EH, UK. s.soond@ich.ucl.ac.uk
Expert Reviews in Molecular Medicine
|July 14, 2006
Summary
Signal transducers and activators of transcription (STATs) are key in cardiac myocyte survival after heart attacks. Understanding STATs offers new therapeutic targets for heart injury.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Cellular Fate Determination
Background:
- Ischaemia-reperfusion (IR) injury significantly impacts myocardial infarction severity.
- Cellular and molecular pathways governing cardiac myocyte fate post-IR are under intense investigation.
- The STAT family of proteins plays a crucial role in mediating cellular responses to IR.
Purpose of the Study:
- To review recent advancements in understanding STAT protein regulation and function in cardioprotective signaling.
- To elucidate the role of STATs in myocardial preconditioning and IR injury.
- To explore therapeutic potential targeting STAT signaling for cardiac myocyte survival.
Main Methods:
- Literature review focusing on recent research (past six years).
- Analysis of signaling pathways involving Janus kinases (JAKs) and STATs.
- Examination of gene expression regulation (pro-survival and apoptotic) by STATs.
Main Results:
- STATs are inducibly activated by JAKs during IR.
- STATs transcriptionally regulate genes involved in cell survival and apoptosis.
- STAT signaling is implicated in both cardioprotective preconditioning and IR injury.
Conclusions:
- STAT proteins are critical mediators of cardiac myocyte response to IR.
- Targeting STAT signaling pathways presents a promising therapeutic strategy for mitigating IR-induced myocardial damage.
- Further research into STAT regulation can lead to novel interventions for heart protection.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:21Paracrine Signaling
Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...